Amedisys Inc
NASDAQ:AMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
90.44
100.99
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Amedisys Inc
NASDAQ:AMED
|
3.3B USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
101.7B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
62B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.3B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.4B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.4B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11.2B AUD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Amedisys Inc
Glance View
Amedisys Inc., headquartered in Baton Rouge, Louisiana, has crafted its narrative at the forefront of America's healthcare sector, by focusing squarely on providing quality home health and hospice services. Established in 1982, the company has steadily expanded its reach, now operating in more than 30 states with a strong network of healthcare professionals dedicated to delivering comprehensive care at the patient's doorstep. Amedisys identifies the growing preference for home-based care among patients and leverages this trend by offering services in home health, hospice, and personal care. This strategic focus aligns with the nationwide shift towards value-based care, where healthcare providers are rewarded for the quality and effectiveness of care given to patients rather than volume. The company's financial engine thrives on two primary service lines: home health and hospice care. Home health services are Amedisys’s backbone, generating revenue by providing skilled medical care and support services at home to patients recovering from illnesses, surgeries, or those managing chronic diseases. Their clinicians, comprising nurses and therapists, work closely with patients to ensure a personalized care plan tailored to individual needs. Hospice care, on the other hand, caters to terminally ill patients, offering support that prioritizes comfort and quality of life in their final days. By understanding the intricacies of Medicare, Medicaid, and private insurance billing, Amedisys efficiently navigates reimbursement pathways, ensuring steady cash flow while aligning with regulatory requirements. This operational model not only feeds into Amedisys's financial health but also solidifies its role as a crucial player in the evolving landscape of at-home healthcare services.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Amedisys Inc is 9.4%, which is above its 3-year median of 8.6%.
Over the last 3 years, Amedisys Inc’s Operating Margin has decreased from 10.3% to 9.4%. During this period, it reached a low of 7.8% on Jun 30, 2023 and a high of 10.3% on Jun 30, 2022.